HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Walmart’s “Big Deal” Sustainable Chemistry Policy Raises Questions

This article was originally published in The Tan Sheet

Executive Summary

Generally seen as a positive step for ingredient disclosure and safer products, Walmart’s Policy for Sustainable Chemistry in Consumables raises questions from consumer advocates. The Campaign for Safe Cosmetics wants the firm to release its list of “high-priority” chemicals and clarify how the policy will enable more informed decisions by shoppers.

You may also be interested in...

Imagining A US Where ‘Clean At Sephora’ Is De Facto Law

NGO-backed legislation at US federal, state and local levels to ban cosmetic ingredients and contain contaminant levels would be largely gratuitous if all cosmetics brands were compelled to be “Clean at Sephora.” For now, companies’ adherence to Sephora’s and peers’ green/clean chemistry principles remains voluntary, but retailers’ role as surrogate regulators seems only to be gaining in strength. 

Target To Reward High-Scoring Personal Care Under Sustainable Standard

Target will show favor to products that rank the highest against its Sustainable Product Standard, the retail giant says. Intended to push vendors to adopt sustainable strategies rather than restricting or banning ingredients outright, the standard will score products from zero to 100 based on ingredient sustainability, transparency and overall environmental impact.

ChromaDex Supplies ‘Healthy Aging’ Ingredient To Male Supplement Brand

ChromaDex Corp. agrees to supply its ‘healthy aging’ nicotinamide riboside ingredient Niagen to New York-based healthcare technology firm Roman Health Ventures, Inc., which plans to use it in its men’s supplement line. ChromaDex’ total sales in the first quarter rose 2% to $14.7m.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts